FTI Consulting Bolsters Threat Intelligence Capabilities with Appointment of Keith Wojcieszek

(NYSE:FCN), WASHINGTON, Sept. 10, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of threat intelligence expert Keith Wojcieszek as a Senior Managing Director in the Cybersecurity practice within the firm's Forensic and Litigation Consulting segment. Mr. Wojcieszek, who is based in Washington, D.C., has more than 15 years of experience […]

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI(R) in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI(R) in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting GlobeNewswire September 10, 2025 NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI(R) (ublituximab-xiiy) data in

U.S. PQFIF Highlights BTQ’s QSSN for Post-Quantum Digital Money; QuINSA Unanimously Advances QSSN as a Global Standards Initiative

— Regulatory validation: The U.S. Post-Quantum Financial Infrastructure Framework (PQFIF) cites BTQ's QSSN as a model for quantum-secure tokenized deposits, signaling a shift from concept to implementation and alignment with emerging NIST PQC standards. — Standards momentum: QuINSA has approved QSSN as a global standard initiative (unanimous), placing it on the ITU / ISO /

GCG Advisory Partners Announces Successful Recapitalization and Strategic Investment from BharCap Partners

Investment and Strategic Partnership to Enable Next Stage of Growth GCG Advisory Partners (“GCG”), parent company of GCG Wealth Management, proudly announces a new chapter in its 31-year history with the successful completion of a recapitalization and a strategic investment from BharCap Partners (“BharCap”), a Greenwich, CT-based private investment firm focused on the financial services

FTI Consulting Bolsters Threat Intelligence Capabilities with Appointment of Keith Wojcieszek

FTI Consulting Bolsters Threat Intelligence Capabilities with Appointment of Keith Wojcieszek GlobeNewswire September 10, 2025 WASHINGTON, Sept. 10, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of threat intelligence expert Keith Wojcieszek as a Senior Managing Director in the Cybersecurity practice within the firm's Forensic and Litigation Consulting segment. Mr.

ATI Chief Financial Officer Don Newman Announces Retirement

Search for successor underway ATI Inc. (NYSE: ATI) today announced that Executive Vice President – Finance and Chief Financial Officer Don Newman has informed the Company he will retire March 1, 2026. As the Company conducts a search for his successor, Newman will continue to serve as Chief Financial Officer until his retirement date. Following

Magellan Health Appoints Dr. Steven E. Pratt as Chief Medical Officer

Magellan Health, Inc., a leader in behavioral health and related services, announced today it has appointed Steven E. Pratt, M.D., as chief medical officer of Magellan Health. In this key leadership role, Dr. Pratt will advance Magellan's clinical mission and further the company's significant leadership capabilities in clinical engagement. https://mma.prnewswire.com/media/2769271/Magellan_Health_New_CMO_Steven_E_Pratt_MD.jpg “Dr. Pratt is an extraordinary

Contact Levi & Korsinsky by September 22, 2025 to Join Class Action Against RxSight, Inc. (RXST)

NEW YORK, NY / ACCESS Newswire / September 10, 2025 / If you suffered a loss on your RxSight, Inc. (NASDAQ:RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=166288&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN(R) at upcoming 150th Annual Meeting of the American Neurological Association

Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN(R) at upcoming 150th Annual Meeting of the American Neurological Association GlobeNewswire September 10, 2025 Poster presentation will feature new data for SYMPAZAN, the only FDA-approved oral film formulation of clobazam for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients two years of

System reform and more supply are key to balancing Ontario’s rental housing market

System reform and more supply are key to balancing Ontario's rental housing market New OREA report advocates for policies that will help create a stronger, more inclusive rental landscape in Ontario GlobeNewswire September 10, 2025 TORONTO , Sept. 10, 2025 (GLOBE NEWSWIRE) — Ontario's rental system is broken. Across the province, too many families, students,

Scroll to Top